Maze Therapeutics, Inc.
Develops genetic precision medicines for common diseases, with a focus on chronic kidney disease.
MAZE | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 171 OYSTER POINT BOULEVARD, SUITE 300, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.mazetx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel, small molecule precision medicines for genetically defined diseases. The company harnesses the power of human genetics and its proprietary Compass platform, which leverages variant functionalization, to identify and develop therapeutic candidates. Maze focuses on common diseases with large unmet medical needs, with a primary commitment to developing targeted treatments for chronic kidney disease. Its most advanced program is directed against APOL1-mediated kidney disease (AMKD), aiming to halt disease progression by imitating the effects of naturally occurring, protective genetic variants.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Maze Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Maze Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Maze Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
